News
Caffeine is a well-known functional ingredient widely used in the nutritional products industry. Energy drinks, sports foods, fortified foods and food supplements (including energy shots) containing caffeine have a significant EU market share, and the impact of the developments on claims will have a major impact on the future of these products which may affect […]
Caffeine is a well-known functional ingredient widely used in the nutritional products industry. Energy drinks, sports foods, fortified foods and food supplements (including energy shots) containing caffeine have a significant EU market share, and the impact of the developments on claims will have a major impact on the future of these products which may affect daily levels and conditions of use.
At the end of 2012, five Article 13(1) health claims relating to caffeine were put “on hold” until assessment by EFSA and final decision by the EU legislators. These five claims are:
| Claim | Conditions of use of the claim | Conditions and/or restrictions of use of the food and/or additional statement or warning |
| Caffeine contributes to an increase in endurance performance | In order to bear the claim, information shall be given to the consumer that the beneficial effect is obtained with caffeine consumption at doses of 3 mg/kg body weight at least one hour prior to exercise, and only if any other caffeine consumption is avoided for at least 12 hours prior to consumption of the product in habitual caffeine consumers. | The claim may be used only for foods targeting adults performing endurance exercise. |
| Caffeine contributes to an increase in endurance capacity | In order to bear the claim, information shall be given to the consumer that the beneficial effect is obtained with caffeine consumption at doses of 3 mg/kg body weight at least one hour prior to exercise and only if any other caffeine consumption is avoided for at least 12 hours prior to consumption of the product in habitual caffeine consumers. | The claim may be used only for foods targeting adults performing endurance exercise. |
| Caffeine contributes to a reduction in the rated perceived exertion/effort during endurance exercise | In order to bear the claim, information shall be given to the consumer that the beneficial effect is obtained with caffeine consumption at doses of 4 mg/kg body weight at least one hour prior to exercise, and only if any other caffeine consumption is avoided for at least 12 hours prior to consumption of the product in habitual caffeine consumers. | The claim may be used only for foods targeting adults performing endurance exercise. |
| Caffeine helps to increase alertness | The claim may be used only for food that contains at least 75 mg caffeine per quantified portion. In order to bear the claim, information shall be given to the consumer not to exceed a daily intake of 300 mg of caffeine. | The claim shall not be used for foods targeting children. |
| Caffeine helps to improve concentration | The claim may be used only for food that contains at least 75 mg caffeine per quantified portion. In order to bear the claim, information shall be given to the consumer not to exceed a daily intake of 300 mg of caffeine. | The claim shall not be used for foods targeting children. |
These “on-hold” health claims can still be used today as long as compliance is ensured with all general principles of the EU’s Nutrition and Health Claims Regulation (EC) No 1924/2006 and other European or national provisions applicable to them. In the meantime, claims may be used under the responsibility of food business operators.
The European Food Safety Authority (EFSA) is currently evaluating five health claims related to caffeine. The EFSA opinion could have a significant impact on the functional food sector. The conditions of use and the minimum dosage initially proposed in particular may be amended. The final EFSA report on the safety of caffeine is scheduled to be provided to the European Commission by 31 December 2013.
EFSA’s opinion on the safety of caffeine will be of great importance in terms of how products containing caffeine that are widely sold will be able to communicate the direct effects of caffeine to the consumer.
It is an issue that needs to be carefully monitored by food manufacturers, because the decisions of the EU and national authorities in the course of 2013 will have a significant impact on specific food categories.
23 Dec 2025
From trade tariffs to heavy metals in protein, we look back at some of the industry’s highlights of 2025 and round up our most-read stories of the year.
Read more
19 Dec 2025
Non-profit organisation the Food Foundation has launched a campaign, “Bang in Some Beans”, designed to increase UK consumers’ legume consumption.
Read more
12 Dec 2025
Europe’s $40.7 billion supplements market is growing fast, fuelled by demand for products that support healthy ageing, mental wellbeing, and preventive health, say experts.
Read more
11 Dec 2025
Whole Foods Market has released its top 2026 trends, predicting that a fibre frenzy will take place next year as health-conscious consumers seek out nutritious, filling options.
Read more
9 Dec 2025
With the launch of Novak Djokovic’s sorghum-based brand, the grain’s popularity in the better-for-you snacking sphere is on the rise, thanks to its nutritional and sensory properties.
Read more
8 Dec 2025
Plant-based dairy is a maturing market that still faces significant hurdles around taste, functionality, nutrition, and price, but industry is innovating fast, according to experts speaking at Fi Europe.
Read more
3 Dec 2025
Food industry stakeholders celebrated as the winners of the Fi Europe Innovation Awards were announced at a ceremony in Paris.
Read more
28 Nov 2025
Entries for the Vitafoods Europe Innovation Awards 2026 are now open! Game-changing companies have until 27 February to submit their entry across eight categories for the chance to win big.
Read more
25 Nov 2025
Cinnamon may be a top functional ingredient, but it needs stronger protocols to ensure it meets EU food safety laws and quality standards, say researchers.
Read more
24 Nov 2025
OXO’s entry into bone broth has turned the spotlight on this small but high-performance category – and there is still scope for growth, especially in the area of GLP-1 support.
Read more